US Stock MarketDetailed Quotes
CNTA Centessa Pharmaceuticals
- 17.040
- -1.150-6.32%
Close Nov 22 16:00 ET
- 17.980
- +0.940+5.52%
Post 20:01 ET
2.25BMarket Cap-11210P/E (TTM)
18.330High16.950Low1.11MVolume18.280Open18.190Pre Close19.38MTurnover1.24%Turnover RatioLossP/E (Static)131.85MShares18.74052wk High4.50P/B1.53BFloat Cap5.58352wk Low--Dividend TTM89.82MShs Float26.900Historical High--Div YieldTTM7.59%Amplitude2.885Historical Low17.444Avg Price1Lot Size
About Centessa Pharmaceuticals Company
Centessa Pharmaceuticals Ltd. operates as pharmaceutical company that develops medicines. The company was founded on October 26, 2020 and is headquartered in Cambridge, the United Kingdom.
Company Profile
SymbolCNTA
Company NameCentessa Pharmaceuticals
Listing DateMay 28, 2021
Issue Price20.00
Founded2013
CEODr. Saurabh Saha, M.D.,PhD
MarketNASDAQ
Employees153
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressThe Dorothy Hodgkin Building,Babraham Research Campus
CityCambridge
ProvinceCambridgeshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeCB22 3FH
Phone44-7391-789784
Websitehttp://www.centessa.com
Company Executives
- Name
- Position
- Salary
- Dr. Saurabh Saha, M.D.,PhD
- Chief Executive Officer and Director
- 2.71M
- Tia Bush
- Chief Quality Officer and Chief Technology Officer
- --
- John Crowley
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Gregory M. Weinhoff, M.B.A.,M.D.
- Chief Business Officer
- --
- Iqbal Hussain
- General Counsel, Chief Compliance Officer and Company Secretary
- --
- Karen Anderson
- Chief People Officer
- --
- Dr. David Chao, PhD
- Chief Administrative Officer
- 1.32M
- Dr. Francesco De Rubertis, PhD
- Chairman of the Board
- --
- Carol Stuckley, M.B.A.
- Independent Director
- 262.69K
- Dr. Brett Zbar, M.D.
- Independent Director
- 257.69K
- Dr. Arjun Goyal, M.B.A.,M.D.,M.Phil
- Independent Director
- 260.19K
- Dr. Mary Lynne Hedley,PhD
- Independent Director
- 255.19K
- Dr. Samarth Kulkarni, PhD
- Independent Director
- 255.19K
- Dr. Mathias Hukkelhoven, PhD
- Independent Director
- 247.69K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data